- Veeva Systems Inc. is a leading provider of industry cloud solutions specifically for the global life sciences sector, achieving total revenues of $3.195 billion in fiscal year 2026, a 16% increase year over year.
- In the past year, Veeva has made significant strides in its R&D Cloud offerings, including securing a top 20 pharmaceutical company as a customer for its RTSM solution and launching its Safety Signal and Workbench product, marking a key execution milestone.
- Veeva's customer base includes major pharmaceutical companies, with notable wins in Q4 FY2026 including a top 20 safety contract, demonstrating the effectiveness of their specialized solutions in the life sciences industry.
- Veeva's ideal buyers are pharmaceutical and biotech companies looking to streamline their operations and leverage AI-driven insights, making it crucial for sales teams to engage with them as Veeva anticipates a 13% growth in subscription revenue for FY2027.
Veeva Systems comprises 19 departments, with a notable concentration in Operations, which employs 1,043 individuals, followed by Engineering with 758 and Information Technology with 727. This distribution indicates a strong emphasis on operational efficiency and technical expertise, essential for the health care sector. The presence of smaller departments such as Finance and Human Resources, with 58 and 52 employees respectively, suggests a streamlined approach to support functions.
The company's workforce is geographically diverse, with Pleasanton, CA, housing the largest concentration of employees at 430, followed by New York, NY, with 344. Other significant locations include San Francisco, CA, and Newburyport, MA. The 'Other' category, accounting for 2,346 employees, indicates a distributed workforce model, reflecting Veeva's ability to operate across various regions while maintaining a core presence in key urban centers.
